SynthesisFrontiers in cardiovascular medicine2026
Comparative safety and effectiveness of midline catheters vs. peripherally inserted central catheters: a systematic review and meta-analysis.
Synthesis in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background & objective: Peripherally inserted central catheters (PICCs) and midline catheters (MCs) are widely used for intravenous therapy, but their relative safety and effectiveness remain uncertain. This systematic review and meta-analysis aimed to compare complication rates between PICCs and MCs. Methods: We systematically searched PubMed, Scopus, Embase, and Web of Science for randomized controlled trials (RCTs) and observational studies evaluating PICCs vs. MCs. Risk of bias was assessed using the Cochrane RoB 2 tool for RCTs and the Newcastle-Ottawa Scale for observational studies. Meta-analyses were performed to calculate pooled risk ratios (RRs) and standardized mean differences (SMDs) with 95% confidence intervals (CIs). Results: Fifteen studies (3 RCTs and 12 cohort studies) including over 27,000 patients were analyzed. PICCs were associated with a significantly higher risk of CRBSIs compared with MCs (RR = 4.18, 95% CI: 2.87-6.08; Conclusion: MCs are associated with a lower risk of bloodstream infections compared with PICCs. PICCs remain appropriate for long-term therapy, while MCs may represent a safer alternative for shorter courses. Device selection should be individualized based on patient risk factors, treatment duration, and clinical context.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.